JP2023544797A5 - - Google Patents
Info
- Publication number
- JP2023544797A5 JP2023544797A5 JP2023521295A JP2023521295A JP2023544797A5 JP 2023544797 A5 JP2023544797 A5 JP 2023544797A5 JP 2023521295 A JP2023521295 A JP 2023521295A JP 2023521295 A JP2023521295 A JP 2023521295A JP 2023544797 A5 JP2023544797 A5 JP 2023544797A5
- Authority
- JP
- Japan
- Prior art keywords
- days
- pharmaceutical composition
- approximately
- hours
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063088826P | 2020-10-07 | 2020-10-07 | |
| US63/088,826 | 2020-10-07 | ||
| US202163147527P | 2021-02-09 | 2021-02-09 | |
| US63/147,527 | 2021-02-09 | ||
| PCT/US2021/053759 WO2022076549A1 (en) | 2020-10-07 | 2021-10-06 | Formulations for suprachoroidal administration such as high viscosity formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023544797A JP2023544797A (ja) | 2023-10-25 |
| JP2023544797A5 true JP2023544797A5 (https=) | 2024-03-06 |
Family
ID=78516913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521295A Pending JP2023544797A (ja) | 2020-10-07 | 2021-10-06 | 脈絡膜上投与用の、高粘度製剤などの製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240024508A1 (https=) |
| EP (1) | EP4225270A1 (https=) |
| JP (1) | JP2023544797A (https=) |
| AU (1) | AU2021358048A1 (https=) |
| CA (1) | CA3198372A1 (https=) |
| MX (1) | MX2023004035A (https=) |
| TW (1) | TW202228648A (https=) |
| WO (1) | WO2022076549A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3727468A4 (en) | 2017-12-19 | 2021-09-22 | Akouos, Inc. | AAV-MEDIATED THERAPEUTIC ANTIBODIES DELIVERY TO THE INTERNAL EAR |
| EP3886946A1 (en) | 2019-06-05 | 2021-10-06 | Regeneron Pharmaceuticals, Inc. | Devices and methods for precision dose delivery |
| IL303317A (en) | 2020-12-01 | 2023-07-01 | Akouos Inc | ANTI-NATURAL ANTIBODY STRUCTURES AND RELATED METHODS FOR THE TREATMENT OF SYMPTOMS ASSOCIATED WITH VESTIBULAR SWANNOMA |
| TW202345913A (zh) * | 2022-04-06 | 2023-12-01 | 美商銳進科斯生物股份有限公司 | 用於脈絡膜上投與之調配物諸如凝膠調配物 |
| IL319873A (en) | 2022-09-30 | 2025-05-01 | Regenxbio Inc | Treatment of eye diseases with recombinant viral vectors containing anti-VEGF FAB |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| WO2024238867A1 (en) | 2023-05-16 | 2024-11-21 | Regenxbio Inc. | Vectorized anti-complement antibodies and administration thereof |
| TW202548025A (zh) | 2024-04-08 | 2025-12-16 | 美商銳進科斯生物股份有限公司 | 載體化抗補體抗體與補體劑及其投與 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2379166C (en) | 1999-08-09 | 2013-03-26 | Targeted Genetics Corporation | Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs |
| MX359371B (es) | 2001-11-13 | 2018-09-25 | Univ Pennsylvania | Un metodo para detectar y/o identificar secuencias del virus adeno-asociado y aislamiento de secuencias novedosas identificadas de ese modo. |
| PT1453547T (pt) | 2001-12-17 | 2016-12-28 | Univ Pennsylvania | Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas |
| EP2345731B1 (en) | 2003-09-30 | 2015-10-21 | The Trustees of the University of Pennsylvania | Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| ES2525067T3 (es) | 2005-04-07 | 2014-12-17 | The Trustees Of The University Of Pennsylvania | Método de incremento de la función de un vector de AAV |
| JP4495210B2 (ja) | 2005-06-09 | 2010-06-30 | パナソニック株式会社 | 振幅誤差補償装置及び直交度誤差補償装置 |
| US8734809B2 (en) | 2009-05-28 | 2014-05-27 | University Of Massachusetts | AAV's and uses thereof |
| US8927514B2 (en) | 2010-04-30 | 2015-01-06 | City Of Hope | Recombinant adeno-associated vectors for targeted treatment |
| US8628966B2 (en) | 2010-04-30 | 2014-01-14 | City Of Hope | CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer |
| WO2012057363A1 (ja) | 2010-10-27 | 2012-05-03 | 学校法人自治医科大学 | 神経系細胞への遺伝子導入のためのアデノ随伴ウイルスビリオン |
| WO2012109570A1 (en) | 2011-02-10 | 2012-08-16 | The University Of North Carolina At Chapel Hill | Viral vectors with modified transduction profiles and methods of making and using the same |
| CN105755044A (zh) | 2011-04-22 | 2016-07-13 | 加利福尼亚大学董事会 | 具有变异衣壳的腺相关病毒病毒体及其使用方法 |
| ES2857773T5 (es) | 2011-08-24 | 2024-06-04 | Univ Leland Stanford Junior | Nuevas proteínas de la cápside de AAV para la transferencia de ácidos nucleicos |
| WO2013170078A1 (en) | 2012-05-09 | 2013-11-14 | Oregon Health & Science University | Adeno associated virus plasmids and vectors |
| CA2905952A1 (en) | 2013-03-13 | 2014-10-02 | The Children's Hospital Of Philadelphia | Adeno-associated virus vectors and methods of use thereof |
| ES2739288T3 (es) | 2013-09-13 | 2020-01-30 | California Inst Of Techn | Recuperación selectiva |
| CN106232618A (zh) | 2013-10-11 | 2016-12-14 | 马萨诸塞眼科耳科诊所 | 预测祖先病毒序列的方法及其用途 |
| WO2015164757A1 (en) | 2014-04-25 | 2015-10-29 | Oregon Health & Science University | Methods of viral neutralizing antibody epitope mapping |
| CN107249522B (zh) | 2014-09-19 | 2021-04-20 | 奥叙拉尔有限公司 | 眼科递送装置 |
| KR20240005973A (ko) | 2016-04-15 | 2024-01-12 | 리젠엑스바이오 인크. | 완전히-인간형의 번역후 변형된 항-VEGF Fab를 이용한 눈 질환의 치료 |
| US10912883B2 (en) | 2017-11-04 | 2021-02-09 | Altaviz, Llc | Gas-powered fluid injection system |
-
2021
- 2021-10-06 CA CA3198372A patent/CA3198372A1/en active Pending
- 2021-10-06 EP EP21802478.4A patent/EP4225270A1/en active Pending
- 2021-10-06 MX MX2023004035A patent/MX2023004035A/es unknown
- 2021-10-06 AU AU2021358048A patent/AU2021358048A1/en not_active Abandoned
- 2021-10-06 US US18/030,630 patent/US20240024508A1/en active Pending
- 2021-10-06 TW TW110137245A patent/TW202228648A/zh unknown
- 2021-10-06 JP JP2023521295A patent/JP2023544797A/ja active Pending
- 2021-10-06 WO PCT/US2021/053759 patent/WO2022076549A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7733706B2 (ja) | 血管新生眼疾患を処置するためのｖｅｇｆアンタゴニストの使用 | |
| JP2023544797A5 (https=) | ||
| US20240024508A1 (en) | Formulations for suprachoroidal administration such as high viscosity formulations | |
| US20230414788A1 (en) | Formulations for suprachoroidal administration such as gel formulations | |
| US20230372538A1 (en) | Formulations for suprachoroidal administration such as formulations with aggregate formation | |
| EP4027983B1 (en) | Treatment of ocular neovascular diseases using aav2 variants encoding aflibercept | |
| TW202117016A (zh) | 使用編碼阿柏西普(aflibercept)之aav2變異體治療眼睛新生血管性疾病的方法 | |
| KR20240145489A (ko) | 아플리베르셉트를 코딩하는 aav2 변이체를 사용하여 안구 신생혈관 질환을 치료하는 방법 | |
| EP4682163A2 (en) | Method of reducing cst fluctuation in neovascular amd by a recombinant adeno-associated virus | |
| US20250339555A1 (en) | Formulations for suprachoroidal administration such as formulations with aggregate formation | |
| JP2024148177A (ja) | アフリベルセプトをコードするａａｖ２バリアントを使用する眼内血管新生疾患を処置する方法 | |
| US20260034243A1 (en) | Pharmaceutical composition comprising a recombinant adeno-associated virus vector with an expression cassette encoding a transgene for suprachoroidal administration | |
| CN116546975A (zh) | 用于脉络膜上施用的制剂诸如高粘度制剂 | |
| CN116635004A (zh) | 用于脉络膜上施用的制剂如凝胶制剂 | |
| CN116601299A (zh) | 用于脉络膜上施用的制剂诸如具有聚集体形成的制剂 | |
| WO2023196835A1 (en) | Formulations for suprachoroidal administration such as gel formulations | |
| HK40130210A (en) | Method of reducing cst fluctuation in neovascular amd by a recombinant adeno-associated virus |